ANCO's ASCO Update on Breast Cancer - Margetuximab + Chemo Improves PFS in HER2+ Breast Cancer & OS Benefit of Adding Atezolizumab to Nab-Paclitaxel in TNBC
By
ANCO’s ASCO Highlights 2019
FEATURING
Helen K. Chew
By
ANCO’s ASCO Highlights 2019
FEATURING
Helen K. Chew
Login to view comments.
Click here to Login